Need Help? Talk to an Expert  +1-800-233-9014

News & Insights

Sam Saleh Announced as New Director of Quality Assurance and Regulatory Affairs

News & Insights

AUSTIN, August 2023: OriGen Biomedical, Inc., a leading producer of cryopreservation and cell culture products, is pleased to announce that Sam Saleh will be joining OriGen Biomedical as Director of Quality Assurance and Regulatory Affairs, effective June 2023. Beth San Segundo, President and CEO, has filled this role since October 2022.

Sam will be joining OriGen from Agilent Technologies, where he was the Director of Global Quality and Regulatory Affairs for over three years. Sam will be bringing experience in global regulation to OriGen to oversee the compliance, risk, regulatory reporting activities, and functions associated with core business activities. Additionally, Sam has held compliance-related positions at various companies for over 10 years. Sam received his Bachelor of Science in Financial & Business Sciences from Philadelphia University.

His expertise will help ensure OriGen Biomedical continues to successfully navigate the highly regulated medical device landscape.

“I look forward to supporting OriGen’s compliance functions as the company continues to evolve and grow. This is a very exciting time for the organization as we continue to enhance a culture of compliance and integrity that will support our ability to make a meaningful impact in patient lives,” said Sam Saleh.

“We’re so excited to welcome Sam to the team,” said Beth San Segundo, President and CEO. “He brings valuable experience and a proven track record of success in compliance. Sam’s experience with laws and regulations within the United States as well as globally, his ability to translate complex regulatory requirements into workable strategies with action plans, and his knack for collaborating with other departments will benefit OriGen greatly.”

OriGen welcomes Sam to this new role and is excited to support his efforts to help create innovative medical products that improve people’s lives.
About OriGen Biomedical
OriGen Biomedical, Inc. is a leading producer of cryopreservation and cell culture products. OriGen’s focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. Our products are designed with the patient and user in mind and we strive to maintain excellent customer service to ensure that patient care is the priority. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention that it will improve patient health. Founded in 1997 and headquartered in Austin, Texas, OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. Follow us on LinkedIn here.

Kirsten Krupps – Marketing Manager
OriGen Biomedical, Inc.

Download this press release here.